In our previous proteomic work on comparison of SEA serum protein profiles at T0 and T1 of both monoclonal therapies, we found upregulation of some protein species of ceruloplasmin (CERU) after 1 month of benralizumab treatment [12], assuming a lowering of asthma-induced oxidative stress. Here, CP is linked to asthma.